Utrecht, Lörrach, 18 March 2024 - Normec, a leading provider of TICC services, is delighted to announce the partnership with Privates Untersuchungsinstitut Heppeler GmbH (Heppeler) an industry-leading provider of microbiological and chemical testing services predominantly for the pharmaceutical industry. Combining Heppeler with the other healthcare testing laboratories and activities within Normec will bring a wealth of experience thereby further solidifying the strong ambition of Normec within the wider Healthcare industry and serving life science customers.
Normec is thrilled to add a specialized laboratory with state of the art equipment, located in southwest Germany, close to the French and the Swiss borders. As customer focus and proximity are key elements of Normec’s service strategy, Heppeler recognized a strong strategic and commercial logic behind this partnership, underpinned by a shared vision of high customer service levels and quality.
Joep Bruins, founder and CEO of Normec commented: “We have known Felix and Axel for many years and look forward to working with them, further developing the Heppeler legacy built since 1947 for many more years to come. It is very rewarding to see our areas of relevance and impact grow within the Healthcare sector.”
Felix and Axel Heppeler, Managing Directors, commented: “With the power and diversity of the Normec Group, the Heppeler DNA and its competencies in the pharmaceutical environment, new ways are emerging to successfully shape the future together. We are very pleased being a member of Normec’s Healthcare activities now.”
Normec:
Frederik Bernoski, General Counsel, frederik.bernoski@normecgroup.com or
Frank Kneepkens, M&A, frank.kneepkens@normecgroup.com
Heppeler:
Felix Heppeler, Managing Director, felix.heppeler@heppeler.com
